Source:http://linkedlifedata.com/resource/pubmed/id/16984596
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
2006-9-20
|
| pubmed:abstractText |
Interferon (IFN)-alpha preparations used in the treatment of viral and neoplastic disease consist of single or multiple IFN-alpha subtypes that may possess different biological activity, but there are no data on liver cancer cells.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0815-9319
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1720-5
|
| pubmed:meshHeading |
pubmed-meshheading:16984596-Antineoplastic Agents,
pubmed-meshheading:16984596-Apoptosis,
pubmed-meshheading:16984596-Cell Cycle,
pubmed-meshheading:16984596-Cell Division,
pubmed-meshheading:16984596-Cell Line, Tumor,
pubmed-meshheading:16984596-Humans,
pubmed-meshheading:16984596-Interferon-alpha,
pubmed-meshheading:16984596-Liver Neoplasms
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Growth inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines.
|
| pubmed:affiliation |
Department of Pathology, Kurume University School of Medicine, Research Center of Innovative Cancer Therapy of the 21st Century COE Program for Medical Science, Kurume University, Kurume, Fukuoka, Japan. hiroyano@med.kurume-u.ac.jp
|
| pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|